ArticlePloS one2022

Inhibiting glutamine utilization creates a synthetic lethality for suppression of ATP citrate lyase in KRas-driven cancer cells.

Ahmet Hatipoglu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.